Plain-English translation of NCT06238765 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →This is a long-term registry study that tracks how well approved atopic dermatitis medications work in teenagers and what side effects they may cause. Researchers will collect information from you over time about how the medication is helping your skin, any challenges you experience, and how it affects your daily life. The goal is to build a large database of real-world experience that helps doctors, patients, and medication makers understand these treatments better.
While medications for severe teenage atopic dermatitis have been approved, there's still a lot to learn about how they work over time in everyday life and how safe they truly are when used by many different patients. This study exists to gather that real-world information so that doctors can make better treatment decisions and patients can understand what to expect.
You likely qualify if…
You likely don't qualify if…
You would be asked to share information about your skin condition, how the medication is working, any side effects you notice, and how the condition affects your daily activities. The study uses standardized questionnaires and check-ins with your healthcare provider to track your progress over time. This is an observational study, meaning you'll continue taking your prescribed medication as normal while researchers collect and analyze your health information to understand long-term safety and effectiveness.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
United States
Sponsor
CorEvitas
Enrollment target
~1,500 participants
Started
December 2023
Primary completion
December 2099
Age range
10 Years – 15 Years
Last updated on clinicaltrials.gov in June 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.